US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Actinium Pharmaceuticals

1.52

+0.09006.29%

Pre-market: 1.51-0.0100-0.66%06:18 EDT

Volume:529.02K

Turnover:760.22K

Market Cap:47.42M

PE:-1.20

High:1.52

Open:1.43

Low:1.35

Close:1.43

Loading ...

Overview Company News Filings

Actinium Pharmaceuticals to Host Investor KOL Call with Dr. Ehab Atallah of the Medical College of Wisconsin and Provide a Pipeline Update Highlighting Revamped Clinical Programs and Expanded Market Opportunities for Actimab-A and Iomab-ACT with Clinical Data in 2H:2025

Promising Phase 1b Trial Results for Actinium Pharmaceuticals’ Actimab-A in r/r AML Support Buy Rating

Actinium Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

H.C. Wainwright Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)

Actinium Pharmaceuticals: Strategic Clinical Advancements and Innovative Trials Drive Buy Rating

Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy

MT Newswires Live

Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-a With Pd-1 Checkpoint Inhibitors Keytruda® and Opdivo®

THOMSON REUTERS

Actinium Pharmaceuticals Inc - Clinical Proof of Concept Data Expected in 2025

THOMSON REUTERS

Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-A with PD-1 Checkpoint Inhibitors KEYTRUDA® and OPDIVO®

Actinium Pharmaceuticals reports Actimab-A + CLAG-M trial results

Actinium Pharmaceuticals Announces Publication of Actimab-A + CLAG-M Trial Results in Patients with Relapsed or Refractory Acute Myeloid Leukemia in the Peer-Reviewed Journal Leukemia

Actinium Pharmaceuticals: Buy Rating Affirmed Amid Promising Clinical Developments and Strategic Partnerships

Actinium Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Actinium begins new Actimab-A trial combining Venetoclax and ASTX-727 to treat patients newly diagnosed with AML in partnership with NCI

H.C. Wainwright Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)

Actinium Pharmaceuticals Announces Initiation of Actimab-A Triplet Combination Frontline Trial Under NCI CRADA with Venetoclax and Taiho Oncology's Hypomethylating Agent ASTX-727 in Patients with Newly Diagnosed AML

H.C. Wainwright Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)

Actinium Pharmaceuticals 2024 Stockholder Meeting Outcomes

Optimistic Buy Rating for Actinium Pharmaceuticals Driven by Strategic Initiatives and Promising Clinical Developments

Actinium Pharmaceuticals Price Target Maintained With a $5.00/Share by Stephens & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATNM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATNM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATNM\",,,,,undefined,":{"symbol":"ATNM","market":"US","secType":"STK","nameCN":"Actinium Pharmaceuticals","latestPrice":1.52,"timestamp":1746043200000,"preClose":1.43,"halted":0,"volume":529019,"hourTrading":{"tag":"盘前","latestPrice":1.51,"preClose":1.52,"latestTime":"06:18 EDT","volume":320,"amount":483.2,"timestamp":1746094703796},"delay":0,"floatShares":31037749,"shares":31195891,"eps":-1.271797,"marketStatus":"Pre-Mkt","change":0.09,"latestTime":"05-01 07:17:34 EDT","open":1.43,"high":1.52,"low":1.345,"amount":760223.7385417,"amplitude":0.122378,"askPrice":1.64,"askSize":100,"bidPrice":1.5,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.271797,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746106200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":1.52,"preHourTrading":{"tag":"盘前","latestPrice":1.51,"preClose":1.52,"latestTime":"06:18 EDT","volume":320,"amount":483.2,"timestamp":1746094703796},"postHourTrading":{"tag":"盘后","latestPrice":1.52,"preClose":1.52,"latestTime":"19:35 EDT","volume":16752,"amount":25304.4324,"timestamp":1746056127722},"volumeRatio":1.120121771878592,"impliedVol":0.4737,"impliedVolPercentile":0.2289},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATNM\",,,,,undefined,":{"symbol":"ATNM","floatShares":31037749,"roa":"-33.25%","roe":"-110.63%","lyrEps":-1.271797,"volumeRatio":1.120121771878592,"shares":31195891,"dividePrice":0,"high":1.52,"amplitude":0.122378,"preClose":1.43,"low":1.345,"week52Low":1.0292,"pbRate":"1.45","psRate":"585.40","week52High":10.24,"institutionHeld":0,"latestPrice":1.52,"eps":-1.271797,"divideRate":0,"volume":529019,"delay":0,"ttmEps":-1.271797,"open":1.43,"prevYearClose":1.26,"prevWeekClose":1.31,"prevMonthClose":1.52,"prevQuarterClose":1.61,"fiveDayClose":1.3,"twentyDayClose":1.49,"sixtyDayClose":1.18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATNM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520927182","title":"Actinium Pharmaceuticals to Host Investor KOL Call with Dr. Ehab Atallah of the Medical College of Wisconsin and Provide a Pipeline Update Highlighting Revamped Clinical Programs and Expanded Market Opportunities for Actimab-A and Iomab-ACT with Clinical Data in 2H:2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520927182","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520927182?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:30","pubTimestamp":1742387400,"startTime":"0","endTime":"0","summary":"-  Actinium to highlight 3 separate multi-billion-dollar market opportunities for Actimab-A and Iomab-ACT in myeloid malignancies, solid tumors and cell & gene therapy conditioning. -  Clinical proof of concept data expected in 2H:2025 from Actimab-A combination with blockbuster immunotherapies KEYTRUDA and OPDIVO in solid tumor indications. - Actimab-A expanded into frontline AML in triplet combination with Venetoclax and ASTX-727, Taiho Oncology's hypomethylating agent, under NCI CRADA with initial clinical data expected by year-end 2025. - Iomab-ACT commercial CAR-T trial to initiate patient enrollment with clinical proof of concept data expected in 2H:2025; Iomab-ACT sickle cell disease trial expected to initiate in 1H:2025. Actimab-A as a mutation agnostic, backbone therapy for myeloid malignancies including AML and myelodysplastic syndromes  across multiple treatment settings. Sandesh Seth, Actinium's Chairman and CEO, said, \"We have made significant progress across our pipeline ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-host-investor-kol-123000877.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-host-investor-kol-123000877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ATNM","KOL","HMA","BK4202","BK4161","BK4139","BK4181","HST","BK4218","CR","BK4585","BK4588","NCI","ACT"],"gpt_icon":0},{"id":"2520183732","title":"Promising Phase 1b Trial Results for Actinium Pharmaceuticals’ Actimab-A in r/r AML Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2520183732","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520183732?lang=en_us&edition=fundamental","pubTime":"2025-03-19 19:56","pubTimestamp":1742385377,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Jason McCarthy has maintained their bullish stance on ATNM stock, giving a Buy rating on March 17. Jason McCarthy’s rating is b...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-1b-trial-results-for-actinium-pharmaceuticals-actimab-a-in-r-r-aml-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-1b-trial-results-for-actinium-pharmaceuticals-actimab-a-in-r-r-aml-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2520798955","title":"Actinium Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520798955","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520798955?lang=en_us&edition=fundamental","pubTime":"2025-03-19 01:07","pubTimestamp":1742317620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ATNM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 18, 2025 13:07 ET (17:07 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM"],"gpt_icon":0},{"id":"2520605043","title":"H.C. Wainwright Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2520605043","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520605043?lang=en_us&edition=fundamental","pubTime":"2025-03-18 22:05","pubTimestamp":1742306716,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report), wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-actinium-pharmaceuticals-atnm-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-actinium-pharmaceuticals-atnm-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2520605014","title":"Actinium Pharmaceuticals: Strategic Clinical Advancements and Innovative Trials Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2520605014","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520605014?lang=en_us&edition=fundamental","pubTime":"2025-03-18 22:05","pubTimestamp":1742306712,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals (ATNM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pant...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-strategic-clinical-advancements-and-innovative-trials-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-strategic-clinical-advancements-and-innovative-trials-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2520759066","title":"Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520759066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520759066?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:37","pubTimestamp":1742301422,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals  said Tuesday it is launching a clinical program consisting of trials studying Actimab-A in combination with either Merck's  Keytruda or Bristol Myers Squibb's  Opdivo for the treatment of multiple solid tumors.Actimab-A is meant to improve the efficacy of the immunotherapies by targeting myeloid derived suppressor cells, the company said.The Actimab-A trials will include several controlled, head-to-head studies that will evaluate the combination of Actimab-A with Keytruda and Opdivo in comparison with the two drugs alone.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","LU1069347547.HKD","LU2133065610.SGD","LU1116320901.HKD","LU1066053197.SGD","LU1430594728.SGD","LU0237698245.USD","LU1934455277.USD","LU1670710661.SGD","LU1066051225.USD","IE00BFTCPJ56.SGD","LU1974910355.USD","LU1868836591.USD","BK4581","IE00BN8TJ469.HKD","MRK","LU1934455863.HKD","LU1585245621.USD","SG9999015341.SGD","BK4585","LU0234572021.USD","LU0203347892.USD","LU0321505868.SGD","LU0114720955.EUR","LU1261432733.SGD","LU0225771236.USD","LU0321505439.SGD","LU2112291526.USD","BK4588","SGXZ57979304.SGD","LU0965509101.SGD","LU1037948897.HKD","LU1670710588.SGD","ATNM","LU2242646821.SGD","LU0203345920.USD","LU1983299246.USD","LU1989772840.SGD","LU2360032135.SGD","IE00BLSP4239.USD","IE0002141913.USD","SG9999002232.USD","LU2106854487.HKD","BMY","LU2324357040.USD","SG9999014575.USD","SG9999002224.SGD","IE00BFXG1179.USD","LU0061475181.USD","LU2461242641.AUD"],"gpt_icon":0},{"id":"2520627921","title":"Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-a With Pd-1 Checkpoint Inhibitors Keytruda® and Opdivo®","url":"https://stock-news.laohu8.com/highlight/detail?id=2520627921","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520627921?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:00","pubTimestamp":1742299221,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUA26DHRZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2520562713","title":"Actinium Pharmaceuticals Inc - Clinical Proof of Concept Data Expected in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520562713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520562713?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:00","pubTimestamp":1742299221,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUA26DHRZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2520784126","title":"Actinium Pharmaceuticals Announces Clinical Trial Program in Solid Tumors Combining Actimab-A with PD-1 Checkpoint Inhibitors KEYTRUDA® and OPDIVO®","url":"https://stock-news.laohu8.com/highlight/detail?id=2520784126","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520784126?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:00","pubTimestamp":1742299200,"startTime":"0","endTime":"0","summary":"- Trials are designed to demonstrate whether the addition of Actimab-A to either KEYTRUDA or OPDIVO can result in improved patient outcomes. - MDSCs – Myeloid Derived Suppressor Cells in the tumor microenvironment are believed to reduce effectiveness of PD-1 inhibitors like KEYTRUDA and OPDIVO. - Trials supported by preclinical data showing Actimab-A can selectively target and deplete MDSCs which express CD33. - Clinical proof of concept data expected in 2025 could potentially open up a multi-billion-dollar market opportunity for Actimab-A as a combination therapy with PD-1 inhibitors in multiple solid tumors. Actimab-A is Actinium's lead radiotherapeutic that delivers Actinium-225, a potent alpha-emitter radioisotope payload that can produce lethal double strand DNA br","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-clinical-trial-120000511.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-clinical-trial-120000511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1037948541.HKD","NCI","HMA","IE00B4R5TH58.HKD","LU1989771016.USD","BK4202","LU1037948897.HKD","LU1093756325.SGD","LU2023250843.SGD","BK4023","LU0289739699.SGD","LU1699723380.USD","SG9999015341.SGD","IE0009355771.USD","LU1057294990.SGD","SG9999015358.SGD","SG9999001176.SGD","SG9999014542.SGD","LU1941712264.USD","LU1929549753.HKD","LU0985320562.USD","IE00BJT1NW94.SGD","LU1989772840.SGD","CR","LU1934455277.USD","LU0266013472.USD","LU1169589451.USD","IE00B2B36J28.USD","LU2324357040.USD","LU1941712348.USD","SG9999002224.SGD","IE00BFTCPJ56.SGD","PD","LU1934455194.USD","LU0320765646.SGD","LU1974910355.USD","LU1983299246.USD","LU1989772923.USD","SG9999002232.USD","IE00BJJMRZ35.SGD","MRK","SG9999013999.USD","ATNM","IE0002141913.USD","LU1116320737.USD","LU2023250504.SGD","SGXZ57979304.SGD","LU0965509283.SGD","LU0965509101.SGD","LU1116320901.HKD"],"gpt_icon":0},{"id":"2520295235","title":"Actinium Pharmaceuticals reports Actimab-A + CLAG-M trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520295235","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520295235?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:59","pubTimestamp":1742216353,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals (ATNM) announced that results from the clinical trial evaluating Actimab-A in combination with the chemotherapy CLAG-M in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/actinium-pharmaceuticals-reports-actimab-a-clag-m-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/actinium-pharmaceuticals-reports-actimab-a-clag-m-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2520443526","title":"Actinium Pharmaceuticals Announces Publication of Actimab-A + CLAG-M Trial Results in Patients with Relapsed or Refractory Acute Myeloid Leukemia in the Peer-Reviewed Journal Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2520443526","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520443526?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:50","pubTimestamp":1742215800,"startTime":"0","endTime":"0","summary":"- Median Overall Survival of 18.4 months with Actimab-A + CLAG-M in patients with relapsed or refractory AML who received 1 or 2 lines of prior therapy. - Mutation agnostic potential of Actimab-A demonstrated by high rates of Complete Remissions and Measurable Residual Disease Negativity in patients with high-risk features including TP53 mutations and prior Venetoclax treatment. - Actimab-A + CLAG-M combination yielded deep and clinically meaningful responses with expected and manageable safety profile supporting planned pivotal Phase 2/3 trial. 52% of patients in the Actimab-A +CLAG-M trial had TP53 mutations, 56% had prior allogeneic stem cell transplant and 56% of patients had prior Venetoclax therapy. Actimab-A + CLAG-M produced high rates of measurable residual disease negativity  including 75% across all patients, 83.3% in patients with a TP53 mutation and 100% in patients with prior Venetoclax therapy. Dr. Sameem Abedin, Associate Professor of Medicine at the Medical College of ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-publication-actimab-125000660.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-publication-actimab-125000660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CR","NCI","HMA","BK4139","BK4539","BK4535","BK4097","OS","BK4192","MCW","ATNM","BK4161","BK4202"],"gpt_icon":0},{"id":"2519853301","title":"Actinium Pharmaceuticals: Buy Rating Affirmed Amid Promising Clinical Developments and Strategic Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2519853301","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519853301?lang=en_us&edition=fundamental","pubTime":"2025-03-13 22:35","pubTimestamp":1741876550,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Justin Walsh has maintained their bullish stance on ATNM stock, giving a Buy rating on March 10. Justin Walsh has given his Bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-buy-rating-affirmed-amid-promising-clinical-developments-and-strategic-partnerships?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-buy-rating-affirmed-amid-promising-clinical-developments-and-strategic-partnerships?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2518725996","title":"Actinium Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2518725996","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518725996?lang=en_us&edition=fundamental","pubTime":"2025-03-11 23:16","pubTimestamp":1741706160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ATNM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2025 11:16 ET (15:16 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM"],"gpt_icon":0},{"id":"2518728711","title":"Actinium begins new Actimab-A trial combining Venetoclax and ASTX-727 to treat patients newly diagnosed with AML in partnership with NCI","url":"https://stock-news.laohu8.com/highlight/detail?id=2518728711","media":"Reuters","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518728711?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:45","pubTimestamp":1741704348,"startTime":"0","endTime":"0","summary":"March 11 (Reuters) - Actinium Pharmaceuticals Inc ::*ACTINIUM PHARMACEUTICALS ANNOUNCES INITIATION OF ACTIMAB-A TRIPLET COMBINATION FRONTLINE TRIAL UNDER NCI CRADA WITH VENETOCLAX AND TAIHO ONCOLOGY'S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nRSD1hrr2l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2518728637","title":"H.C. Wainwright Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518728637","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518728637?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:36","pubTimestamp":1741703789,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report),...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-actinium-pharmaceuticals-atnm-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-actinium-pharmaceuticals-atnm-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2518745220","title":"Actinium Pharmaceuticals Announces Initiation of Actimab-A Triplet Combination Frontline Trial Under NCI CRADA with Venetoclax and Taiho Oncology's Hypomethylating Agent ASTX-727 in Patients with Newly Diagnosed AML","url":"https://stock-news.laohu8.com/highlight/detail?id=2518745220","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518745220?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:30","pubTimestamp":1741696200,"startTime":"0","endTime":"0","summary":"Represents first ever triplet combination using targeted radiotherapy as a backbone therapy inAML with initial clinical data expected in 2H:2025. Dr. Avinash Desai, Actinium's Chief Medical Officer, commented, \"We are incredibly excited that the first Actimab-A trial initiated under our CRADA with the NCI is this triplet combination with Venetoclax and Taiho's ASTX-727. While Ven-HMA has positively impacted outcomes in AML, a significant number of patients have poor responses or relapse quickly resulting in dismal outcomes. We believe Actimab-A's potentially synergistic, and mutation agnostic mechanism of action can improve clinical outcomes for these patients by producing deeper remissions, including measurable residual disease negativity, that are more durable. Due to its mutation agnostic mechanism, Actimab-A can overcome high-risk features, such as TP53 mutations, and has demonstrated the ability to improve outcomes in these patients where Ven-HMA has had limited success. This trip","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-initiation-actimab-123000179.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/actinium-pharmaceuticals-announces-initiation-actimab-123000179.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4161","CR","NCI","ATNM","HMA","BK4202"],"gpt_icon":0},{"id":"2505721199","title":"H.C. Wainwright Sticks to Their Buy Rating for Actinium Pharmaceuticals (ATNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2505721199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505721199?lang=en_us&edition=fundamental","pubTime":"2025-01-22 22:55","pubTimestamp":1737557719,"startTime":"0","endTime":"0","summary":"In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report), wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-actinium-pharmaceuticals-atnm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-actinium-pharmaceuticals-atnm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2486737383","title":"Actinium Pharmaceuticals 2024 Stockholder Meeting Outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2486737383","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486737383?lang=en_us&edition=fundamental","pubTime":"2024-11-28 06:01","pubTimestamp":1732744882,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals ( ($ATNM) ) just unveiled an announcement. Actinium Pharmaceuticals, Inc. held its 2024 annual stockholder meeting where S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinium-pharmaceuticals-2024-stockholder-meeting-outcomes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinium-pharmaceuticals-2024-stockholder-meeting-outcomes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2485125382","title":"Optimistic Buy Rating for Actinium Pharmaceuticals Driven by Strategic Initiatives and Promising Clinical Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2485125382","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485125382?lang=en_us&edition=fundamental","pubTime":"2024-11-21 02:05","pubTimestamp":1732125943,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals (ATNM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/optimistic-buy-rating-for-actinium-pharmaceuticals-driven-by-strategic-initiatives-and-promising-clinical-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/optimistic-buy-rating-for-actinium-pharmaceuticals-driven-by-strategic-initiatives-and-promising-clinical-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2484418975","title":"Actinium Pharmaceuticals Price Target Maintained With a $5.00/Share by Stephens & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2484418975","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484418975?lang=en_us&edition=fundamental","pubTime":"2024-11-20 02:03","pubTimestamp":1732039380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ATNM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 19, 2024 13:03 ET (18:03 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATNM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"ATNM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"ATNM","fiscalQuarterEnding":"2024/09","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2024-08-05","symbol":"ATNM","fiscalQuarterEnding":"2024/06","expectedEps":-0.48,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2024-04-26","symbol":"ATNM","fiscalQuarterEnding":"2024/03","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714104000000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2024-03-29","symbol":"ATNM","fiscalQuarterEnding":"2023/12","expectedEps":-0.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1711684800000,"reportTimeType":"post","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATNM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATNM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1723176000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATNM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATNM","date":"2025-04-29","current":-1.060447,"percent":0.933279,"low":-13.279332,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"high":-0.808203,"avg":-5.252871,"sd":2.446982,"marketCap":40554658},"quantilePoints":[{"date":"2020-05-01","current":-2.291446,"twenty":-3.773679,"median":-2.80574,"eighty":-1.751477,"marketCap":54116501},{"date":"2020-05-08","current":-2.54587,"twenty":-3.750768,"median":-2.799832,"eighty":-1.751477,"marketCap":55754562},{"date":"2020-05-15","current":-2.479384,"twenty":-3.750768,"median":-2.786754,"eighty":-1.751477,"marketCap":54298513},{"date":"2020-05-22","current":-2.770262,"twenty":-3.749357,"median":-2.774204,"eighty":-1.751477,"marketCap":60668730},{"date":"2020-05-29","current":-2.946173,"twenty":-3.725455,"median":-2.771834,"eighty":-1.751477,"marketCap":64521194},{"date":"2020-06-05","current":-4.155392,"twenty":-3.723555,"median":-2.771834,"eighty":-1.751477,"marketCap":91003095},{"date":"2020-06-12","current":-6.233089,"twenty":-3.723555,"median":-2.771834,"eighty":-1.751477,"marketCap":136504652},{"date":"2020-06-19","current":-7.242734,"twenty":-3.724693,"median":-2.771834,"eighty":-1.751477,"marketCap":158615869},{"date":"2020-06-26","current":-6.894763,"twenty":-3.724693,"median":-2.771834,"eighty":-1.751477,"marketCap":150995312},{"date":"2020-07-02","current":-5.665688,"twenty":-3.724693,"median":-2.771834,"eighty":-1.751477,"marketCap":124078563},{"date":"2020-07-10","current":-6.658086,"twenty":-3.747566,"median":-2.771834,"eighty":-1.751477,"marketCap":145812082},{"date":"2020-07-17","current":-7.217437,"twenty":-3.76424,"median":-2.771834,"eighty":-1.751477,"marketCap":158061877},{"date":"2020-07-24","current":-9.597387,"twenty":-3.787582,"median":-2.771834,"eighty":-1.751477,"marketCap":210182776},{"date":"2020-07-31","current":-10.398523,"twenty":-3.7977,"median":-2.771834,"eighty":-1.751477,"marketCap":227727643},{"date":"2020-08-07","current":-7.911092,"twenty":-3.810149,"median":-2.782388,"eighty":-1.751477,"marketCap":173252923},{"date":"2020-08-14","current":-6.205548,"twenty":-3.810149,"median":-2.782388,"eighty":-1.751477,"marketCap":133406880},{"date":"2020-08-21","current":-5.864306,"twenty":-3.810149,"median":-2.782388,"eighty":-1.751477,"marketCap":126070860},{"date":"2020-08-28","current":-5.390359,"twenty":-3.810336,"median":-2.782388,"eighty":-1.751477,"marketCap":115881943},{"date":"2020-09-04","current":-4.66996,"twenty":-3.810336,"median":-2.782388,"eighty":-1.751477,"marketCap":100394790},{"date":"2020-09-11","current":-5.38404,"twenty":-3.810336,"median":-2.782388,"eighty":-1.751477,"marketCap":115746091},{"date":"2020-09-18","current":-6.527832,"twenty":-3.810336,"median":-2.782388,"eighty":-1.751477,"marketCap":140335343},{"date":"2020-09-25","current":-5.820071,"twenty":-3.810336,"median":-2.782388,"eighty":-1.751477,"marketCap":125119894},{"date":"2020-10-02","current":-5.801113,"twenty":-3.817358,"median":-2.782388,"eighty":-1.751477,"marketCap":124712337},{"date":"2020-10-09","current":-6.661177,"twenty":-3.825987,"median":-2.782388,"eighty":-1.751477,"marketCap":143201973},{"date":"2020-10-16","current":-7.571242,"twenty":-3.825987,"median":-2.782388,"eighty":-1.751477,"marketCap":162766569},{"date":"2020-10-23","current":-7.498581,"twenty":-3.825987,"median":-2.782388,"eighty":-1.751477,"marketCap":153256002},{"date":"2020-10-30","current":-6.621088,"twenty":-3.825987,"median":-2.782388,"eighty":-1.751477,"marketCap":135321789},{"date":"2020-11-06","current":-7.604944,"twenty":-3.838273,"median":-2.782388,"eighty":-1.751477,"marketCap":155429846},{"date":"2020-11-13","current":-7.983862,"twenty":-3.86629,"median":-2.782388,"eighty":-1.751477,"marketCap":163174165},{"date":"2020-11-20","current":-7.418809,"twenty":-3.872917,"median":-2.782388,"eighty":-1.751477,"marketCap":151625619},{"date":"2020-11-27","current":-7.438752,"twenty":-3.894185,"median":-2.782388,"eighty":-1.751477,"marketCap":152033214},{"date":"2020-12-04","current":-7.206083,"twenty":-3.922323,"median":-2.782388,"eighty":-1.751477,"marketCap":147277931},{"date":"2020-12-11","current":-7.631535,"twenty":-3.96628,"median":-2.782388,"eighty":-1.751477,"marketCap":155973307},{"date":"2020-12-18","current":-7.538467,"twenty":-4.006239,"median":-2.782388,"eighty":-1.751477,"marketCap":154071193},{"date":"2020-12-24","current":-7.345685,"twenty":-4.008026,"median":-2.782388,"eighty":-1.751477,"marketCap":150131101},{"date":"2020-12-31","current":-5.185189,"twenty":-4.008026,"median":-2.782388,"eighty":-1.751477,"marketCap":105974895},{"date":"2021-01-08","current":-5.477687,"twenty":-4.008026,"median":-2.782388,"eighty":-1.751477,"marketCap":111952966},{"date":"2021-01-15","current":-5.517573,"twenty":-4.031758,"median":-2.782388,"eighty":-1.751477,"marketCap":112768157},{"date":"2021-01-22","current":-5.557459,"twenty":-4.064172,"median":-2.782388,"eighty":-1.751477,"marketCap":113583349},{"date":"2021-01-29","current":-5.238371,"twenty":-4.134343,"median":-2.782388,"eighty":-1.751477,"marketCap":107061817},{"date":"2021-02-05","current":-6.375123,"twenty":-4.17175,"median":-2.782388,"eighty":-1.751477,"marketCap":130294774},{"date":"2021-02-12","current":-6.149102,"twenty":-4.204316,"median":-2.782388,"eighty":-1.751477,"marketCap":125675356},{"date":"2021-02-19","current":-5.856605,"twenty":-4.232345,"median":-2.782388,"eighty":-1.751477,"marketCap":119697285},{"date":"2021-02-26","current":-5.358029,"twenty":-4.260374,"median":-2.782388,"eighty":-1.751477,"marketCap":109507391},{"date":"2021-03-05","current":-5.151951,"twenty":-4.316431,"median":-2.782032,"eighty":-1.751353,"marketCap":105295568},{"date":"2021-03-12","current":-6.102569,"twenty":-4.34446,"median":-2.782032,"eighty":-1.751353,"marketCap":124724299},{"date":"2021-03-19","current":-5.889843,"twenty":-4.65353,"median":-2.782032,"eighty":-1.751353,"marketCap":120376611},{"date":"2021-03-26","current":-5.590697,"twenty":-5.123456,"median":-2.782388,"eighty":-1.751477,"marketCap":114262675},{"date":"2021-04-01","current":-6.982662,"twenty":-5.222416,"median":-2.782388,"eighty":-1.751477,"marketCap":155119842},{"date":"2021-04-09","current":-7.043306,"twenty":-5.251335,"median":-2.782032,"eighty":-1.751353,"marketCap":156467036},{"date":"2021-04-16","current":-6.462861,"twenty":-5.352711,"median":-2.782032,"eighty":-1.751353,"marketCap":143572459},{"date":"2021-04-23","current":-6.783405,"twenty":-5.381497,"median":-2.782032,"eighty":-1.751353,"marketCap":150693345},{"date":"2021-04-30","current":-6.636128,"twenty":-5.41615,"median":-2.782032,"eighty":-1.751353,"marketCap":147421587},{"date":"2021-05-07","current":-6.315584,"twenty":-5.475028,"median":-2.782032,"eighty":-1.751353,"marketCap":140300701},{"date":"2021-05-14","current":-6.548439,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":143181621},{"date":"2021-05-21","current":-7.425875,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":162366746},{"date":"2021-05-28","current":-7.536708,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":164790131},{"date":"2021-06-04","current":-7.666015,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":167617412},{"date":"2021-06-11","current":-7.859974,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":171858335},{"date":"2021-06-18","current":-7.416638,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":162164798},{"date":"2021-06-25","current":-7.767613,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":169838848},{"date":"2021-07-02","current":-7.084137,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":154894645},{"date":"2021-07-09","current":-6.705454,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":146614748},{"date":"2021-07-16","current":-6.631565,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":144999159},{"date":"2021-07-23","current":-6.529967,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":142777723},{"date":"2021-07-30","current":-6.381858,"twenty":-5.501619,"median":-2.782032,"eighty":-1.751353,"marketCap":142066551},{"date":"2021-08-06","current":-6.631,"twenty":-5.539494,"median":-2.782032,"eighty":-1.751353,"marketCap":147612692},{"date":"2021-08-13","current":-6.056058,"twenty":-5.590697,"median":-2.782032,"eighty":-1.751353,"marketCap":134813904},{"date":"2021-08-20","current":-5.778169,"twenty":-5.614629,"median":-2.782032,"eighty":-1.751353,"marketCap":128627823},{"date":"2021-08-27","current":-5.806916,"twenty":-5.640622,"median":-2.782032,"eighty":-1.751353,"marketCap":129267762},{"date":"2021-09-03","current":-6.084805,"twenty":-5.722321,"median":-2.782032,"eighty":-1.751353,"marketCap":135453843},{"date":"2021-09-10","current":-5.768587,"twenty":-5.785835,"median":-2.782032,"eighty":-1.751353,"marketCap":128414510},{"date":"2021-09-17","current":-7.502996,"twenty":-5.805755,"median":-2.782032,"eighty":-1.751353,"marketCap":167024188},{"date":"2021-09-24","current":-9.266152,"twenty":-5.825538,"median":-2.782032,"eighty":-1.751353,"marketCap":206273806},{"date":"2021-10-01","current":-8.221674,"twenty":-5.861923,"median":-2.782032,"eighty":-1.751353,"marketCap":183022674},{"date":"2021-10-08","current":-7.675478,"twenty":-5.872646,"median":-2.782388,"eighty":-1.751477,"marketCap":170863825},{"date":"2021-10-15","current":-7.704226,"twenty":-5.908489,"median":-2.782388,"eighty":-1.751477,"marketCap":171503764},{"date":"2021-10-22","current":-8.162229,"twenty":-5.955546,"median":-2.786754,"eighty":-1.751477,"marketCap":181699377},{"date":"2021-10-29","current":-7.766484,"twenty":-6.037658,"median":-2.799692,"eighty":-1.751477,"marketCap":172889710},{"date":"2021-11-05","current":-8.19191,"twenty":-6.083553,"median":-2.80245,"eighty":-1.751477,"marketCap":182360102},{"date":"2021-11-12","current":-7.586665,"twenty":-6.12087,"median":-2.817736,"eighty":-1.751477,"marketCap":175585778},{"date":"2021-11-19","current":-7.253499,"twenty":-6.156519,"median":-2.817736,"eighty":-1.751477,"marketCap":167874985},{"date":"2021-11-26","current":-6.939371,"twenty":-6.198706,"median":-2.820255,"eighty":-1.751477,"marketCap":160604809},{"date":"2021-12-03","current":-6.044583,"twenty":-6.219755,"median":-2.829029,"eighty":-1.751477,"marketCap":139895821},{"date":"2021-12-10","current":-6.520534,"twenty":-6.241046,"median":-2.833898,"eighty":-1.751477,"marketCap":150911240},{"date":"2021-12-17","current":-6.663319,"twenty":-6.265854,"median":-2.852054,"eighty":-1.751477,"marketCap":154215866},{"date":"2021-12-23","current":-6.339673,"twenty":-6.291084,"median":-2.855689,"eighty":-1.751477,"marketCap":146725381},{"date":"2021-12-31","current":-5.720936,"twenty":-6.291084,"median":-2.8711,"eighty":-1.751477,"marketCap":132405336},{"date":"2022-01-07","current":-5.854202,"twenty":-6.290587,"median":-2.879943,"eighty":-1.7516,"marketCap":135489653},{"date":"2022-01-14","current":-5.530555,"twenty":-6.290587,"median":-2.883827,"eighty":-1.7516,"marketCap":127999168},{"date":"2022-01-21","current":-5.09268,"twenty":-6.290587,"median":-2.913684,"eighty":-1.7516,"marketCap":117864983},{"date":"2022-01-28","current":-4.978452,"twenty":-6.290091,"median":-2.928404,"eighty":-1.751724,"marketCap":115221282},{"date":"2022-02-04","current":-4.911818,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":113679124},{"date":"2022-02-11","current":-4.816628,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":111476040},{"date":"2022-02-18","current":-4.835666,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":111916657},{"date":"2022-02-25","current":-4.807109,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":111255731},{"date":"2022-03-04","current":-4.730957,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":109493264},{"date":"2022-03-11","current":-4.569133,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":105748022},{"date":"2022-03-18","current":-4.845185,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":112136965},{"date":"2022-03-25","current":-4.549642,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":112712827},{"date":"2022-04-01","current":-4.585395,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":113598586},{"date":"2022-04-08","current":-4.647964,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":115148664},{"date":"2022-04-14","current":-6.078107,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":150579023},{"date":"2022-04-22","current":-6.131737,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":151907661},{"date":"2022-04-29","current":-5.345159,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":132420964},{"date":"2022-05-06","current":-5.112761,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":126663531},{"date":"2022-05-13","current":-5.563231,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":136760909},{"date":"2022-05-20","current":-5.853487,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":143896261},{"date":"2022-05-27","current":-5.447129,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":133906768},{"date":"2022-06-03","current":-5.185899,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":127484952},{"date":"2022-06-10","current":-4.914994,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":120825290},{"date":"2022-06-17","current":-4.992395,"twenty":-6.296594,"median":-2.939684,"eighty":-1.751724,"marketCap":122728050},{"date":"2022-06-24","current":-4.944019,"twenty":-6.297837,"median":-2.93857,"eighty":-1.7516,"marketCap":121538825},{"date":"2022-07-01","current":-4.798891,"twenty":-6.297837,"median":-2.93857,"eighty":-1.7516,"marketCap":117971149},{"date":"2022-07-08","current":-5.050446,"twenty":-6.297837,"median":-2.941386,"eighty":-1.7516,"marketCap":124155121},{"date":"2022-07-15","current":-4.885968,"twenty":-6.297837,"median":-2.957708,"eighty":-1.7516,"marketCap":120111755},{"date":"2022-07-22","current":-4.682789,"twenty":-6.297837,"median":-2.982798,"eighty":-1.7516,"marketCap":115117009},{"date":"2022-07-29","current":-4.769866,"twenty":-6.297837,"median":-3.02078,"eighty":-1.7516,"marketCap":117257614},{"date":"2022-08-05","current":-5.543881,"twenty":-6.297837,"median":-3.040268,"eighty":-1.7516,"marketCap":136285219},{"date":"2022-08-12","current":-5.446277,"twenty":-6.297837,"median":-3.06668,"eighty":-1.7516,"marketCap":148841305},{"date":"2022-08-19","current":-5.418631,"twenty":-6.297837,"median":-3.084118,"eighty":-1.7516,"marketCap":148085765},{"date":"2022-08-26","current":-6.146644,"twenty":-6.297837,"median":-3.118224,"eighty":-1.7516,"marketCap":167981642},{"date":"2022-09-02","current":-7.335426,"twenty":-6.309848,"median":-3.142585,"eighty":-1.7516,"marketCap":200469845},{"date":"2022-09-09","current":-7.814624,"twenty":-6.317251,"median":-3.162074,"eighty":-1.7516,"marketCap":213565865},{"date":"2022-09-16","current":-7.353856,"twenty":-6.347186,"median":-3.184394,"eighty":-1.7516,"marketCap":200973538},{"date":"2022-09-23","current":-6.727212,"twenty":-6.375565,"median":-3.188508,"eighty":-1.7516,"marketCap":183847974},{"date":"2022-09-30","current":-6.800935,"twenty":-6.426974,"median":-3.264391,"eighty":-1.7516,"marketCap":185862746},{"date":"2022-10-07","current":-7.095826,"twenty":-6.466892,"median":-3.372124,"eighty":-1.7516,"marketCap":193921835},{"date":"2022-10-14","current":-6.81015,"twenty":-6.493464,"median":-3.432024,"eighty":-1.7516,"marketCap":186114593},{"date":"2022-10-21","current":-6.644274,"twenty":-6.514823,"median":-3.497692,"eighty":-1.7516,"marketCap":181581355},{"date":"2022-10-28","current":-8.966544,"twenty":-6.528686,"median":-3.556724,"eighty":-1.7516,"marketCap":245046683},{"date":"2022-11-04","current":-10.044741,"twenty":-6.545571,"median":-3.607395,"eighty":-1.7516,"marketCap":274512728},{"date":"2022-11-11","current":-10.9202,"twenty":-6.573735,"median":-3.676581,"eighty":-1.7516,"marketCap":298438149},{"date":"2022-11-18","current":-10.007105,"twenty":-6.621418,"median":-3.751613,"eighty":-1.7516,"marketCap":304015840},{"date":"2022-11-25","current":-9.227003,"twenty":-6.631226,"median":-3.851007,"eighty":-1.7516,"marketCap":280316366},{"date":"2022-12-02","current":-9.453484,"twenty":-6.646579,"median":-4.155392,"eighty":-1.7516,"marketCap":287196858},{"date":"2022-12-09","current":-9.034075,"twenty":-6.660035,"median":-4.496012,"eighty":-1.7516,"marketCap":274455205},{"date":"2022-12-16","current":-9.302497,"twenty":-6.679082,"median":-4.567519,"eighty":-1.7516,"marketCap":282609863},{"date":"2022-12-23","current":-8.421738,"twenty":-6.724542,"median":-4.587809,"eighty":-1.7516,"marketCap":255852392},{"date":"2022-12-30","current":-8.933417,"twenty":-6.753947,"median":-4.634413,"eighty":-1.7516,"marketCap":271397208},{"date":"2023-01-06","current":-8.287527,"twenty":-6.778375,"median":-4.653764,"eighty":-1.7516,"marketCap":251775063},{"date":"2023-01-13","current":-8.514008,"twenty":-6.80712,"median":-4.692464,"eighty":-1.7516,"marketCap":258655555},{"date":"2023-01-20","current":-9.227003,"twenty":-6.81015,"median":-4.72841,"eighty":-1.7516,"marketCap":280316366},{"date":"2023-01-27","current":-9.696742,"twenty":-6.841186,"median":-4.769866,"eighty":-1.7516,"marketCap":294587017},{"date":"2023-02-03","current":-10.241974,"twenty":-6.890177,"median":-4.79759,"eighty":-1.7516,"marketCap":311151166},{"date":"2023-02-10","current":-10.90464,"twenty":-6.916268,"median":-4.808567,"eighty":-1.755491,"marketCap":331282978},{"date":"2023-02-17","current":-11.542143,"twenty":-6.965611,"median":-4.818242,"eighty":-1.762031,"marketCap":350650290},{"date":"2023-02-24","current":-7.767459,"twenty":-7.019706,"median":-4.835666,"eighty":-1.778348,"marketCap":235975413},{"date":"2023-03-03","current":-8.497231,"twenty":-7.046348,"median":-4.884816,"eighty":-1.798523,"marketCap":258145889},{"date":"2023-03-10","current":-7.138345,"twenty":-7.08043,"median":-4.911818,"eighty":-1.80875,"marketCap":216862934},{"date":"2023-03-17","current":-7.784236,"twenty":-7.114972,"median":-4.933993,"eighty":-1.831633,"marketCap":236485079},{"date":"2023-03-24","current":-7.834565,"twenty":-7.149721,"median":-4.949894,"eighty":-1.842907,"marketCap":238014078},{"date":"2023-03-31","current":-7.926835,"twenty":-7.207328,"median":-4.990183,"eighty":-1.866152,"marketCap":240817241},{"date":"2023-04-06","current":-7.306109,"twenty":-7.239688,"median":-5.004539,"eighty":-1.891427,"marketCap":221959595},{"date":"2023-04-14","current":-7.691966,"twenty":-7.254508,"median":-5.040771,"eighty":-1.905611,"marketCap":233681916},{"date":"2023-04-21","current":-6.93556,"twenty":-7.254508,"median":-5.064123,"eighty":-1.925645,"marketCap":228991393},{"date":"2023-04-28","current":-6.834254,"twenty":-7.259978,"median":-5.09268,"eighty":-1.966075,"marketCap":225646574},{"date":"2023-05-05","current":-6.912182,"twenty":-7.259978,"median":-5.127848,"eighty":-1.993151,"marketCap":228219511},{"date":"2023-05-12","current":-6.452409,"twenty":-7.259978,"median":-5.159313,"eighty":-2.00625,"marketCap":213039183},{"date":"2023-05-19","current":-5.532558,"twenty":-7.259978,"median":-5.225075,"eighty":-2.02033,"marketCap":215354826},{"date":"2023-05-26","current":-5.597458,"twenty":-7.259978,"median":-5.238371,"eighty":-2.043298,"marketCap":217881064},{"date":"2023-06-02","current":-5.658521,"twenty":-7.261956,"median":-5.25221,"eighty":-2.054966,"marketCap":220257948},{"date":"2023-06-09","current":-5.88242,"twenty":-7.263934,"median":-5.28259,"eighty":-2.061028,"marketCap":228973191},{"date":"2023-06-16","current":-5.251434,"twenty":-7.263934,"median":-5.321351,"eighty":-2.082067,"marketCap":204412053},{"date":"2023-06-23","current":-5.475332,"twenty":-7.265912,"median":-5.34293,"eighty":-2.081273,"marketCap":213127295},{"date":"2023-06-30","current":-4.851131,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":188830255},{"date":"2023-07-07","current":-4.966472,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":193319926},{"date":"2023-07-14","current":-4.851131,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":188830255},{"date":"2023-07-21","current":-4.891839,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":190414845},{"date":"2023-07-28","current":-4.688295,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":182491897},{"date":"2023-08-04","current":-4.661156,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":181435504},{"date":"2023-08-11","current":-4.464397,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":173776655},{"date":"2023-08-18","current":-3.583054,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":166035160},{"date":"2023-08-25","current":-3.484011,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":161445570},{"date":"2023-09-01","current":-3.501489,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":162255497},{"date":"2023-09-08","current":-3.752011,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":173864460},{"date":"2023-09-15","current":-3.87436,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":179533953},{"date":"2023-09-22","current":-3.66462,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":169814822},{"date":"2023-09-29","current":-3.588881,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":166305135},{"date":"2023-10-06","current":-3.542272,"twenty":-7.265912,"median":-5.351594,"eighty":-2.078635,"marketCap":164145328},{"date":"2023-10-13","current":-3.460706,"twenty":-7.265912,"median":-5.351594,"eighty":-2.078635,"marketCap":160365666},{"date":"2023-10-20","current":-3.355836,"twenty":-7.265912,"median":-5.351594,"eighty":-2.078635,"marketCap":155506101},{"date":"2023-10-27","current":-3.227662,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":149566631},{"date":"2023-11-03","current":-2.466025,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":123648948},{"date":"2023-11-10","current":-2.553215,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":128020769},{"date":"2023-11-17","current":-2.482141,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":124457022},{"date":"2023-11-24","current":-2.438403,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":122263946},{"date":"2023-12-01","current":-2.50401,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":125553559},{"date":"2023-12-08","current":-2.897653,"twenty":-7.265912,"median":-5.358029,"eighty":-2.075996,"marketCap":145291237},{"date":"2023-12-15","current":-2.782841,"twenty":-7.265912,"median":-5.358029,"eighty":-2.075996,"marketCap":139534414},{"date":"2023-12-22","current":-2.618823,"twenty":-7.265912,"median":-5.358029,"eighty":-2.097526,"marketCap":131310382},{"date":"2023-12-29","current":-2.733635,"twenty":-7.265912,"median":-5.358029,"eighty":-2.124592,"marketCap":137067205},{"date":"2024-01-05","current":-2.853915,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":143098162},{"date":"2024-01-12","current":-2.826579,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":141727489},{"date":"2024-01-19","current":-2.733635,"twenty":-7.267091,"median":-5.358029,"eighty":-2.138602,"marketCap":137067205},{"date":"2024-01-26","current":-2.86485,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":143646430},{"date":"2024-02-02","current":-3.039802,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":152418731},{"date":"2024-02-09","current":-2.851674,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":142985799},{"date":"2024-02-16","current":-3.255892,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":163253690},{"date":"2024-02-23","current":-3.732094,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":187130930},{"date":"2024-03-01","current":-4.723259,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":236828907},{"date":"2024-03-08","current":-4.213833,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":211285813},{"date":"2024-03-15","current":-3.471844,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":174081740},{"date":"2024-03-22","current":-5.044418,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":252932162},{"date":"2024-03-28","current":-4.396562,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":220448010},{"date":"2024-04-05","current":-5.497751,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":268389232},{"date":"2024-04-12","current":-5.473665,"twenty":-7.266502,"median":-5.381721,"eighty":-2.143272,"marketCap":267213375},{"date":"2024-04-19","current":-4.01643,"twenty":-7.266502,"median":-5.384329,"eighty":-2.165076,"marketCap":196074061},{"date":"2024-04-26","current":-3.950192,"twenty":-7.265912,"median":-5.38404,"eighty":-2.285319,"marketCap":192840456},{"date":"2024-05-03","current":-5.610325,"twenty":-7.265912,"median":-5.384619,"eighty":-2.317135,"marketCap":260605196},{"date":"2024-05-10","current":-5.706502,"twenty":-7.265912,"median":-5.393914,"eighty":-2.369797,"marketCap":265072713},{"date":"2024-05-17","current":-6.315623,"twenty":-7.265912,"median":-5.409317,"eighty":-2.438403,"marketCap":293366992},{"date":"2024-05-24","current":-5.398735,"twenty":-7.265912,"median":-5.418631,"eighty":-2.471635,"marketCap":250776657},{"date":"2024-05-31","current":-5.19997,"twenty":-7.265912,"median":-5.41947,"eighty":-2.487608,"marketCap":241543787},{"date":"2024-06-07","current":-5.123028,"twenty":-7.265912,"median":-5.424506,"eighty":-2.50401,"marketCap":237969773},{"date":"2024-06-14","current":-5.142263,"twenty":-7.266502,"median":-5.425176,"eighty":-2.545152,"marketCap":238863277},{"date":"2024-06-21","current":-4.840909,"twenty":-7.267091,"median":-5.425846,"eighty":-2.609077,"marketCap":224865055},{"date":"2024-06-28","current":-4.73832,"twenty":-7.26886,"median":-5.446277,"eighty":-2.646159,"marketCap":220099702},{"date":"2024-07-05","current":-4.66779,"twenty":-7.26886,"median":-5.446277,"eighty":-2.721782,"marketCap":216823523},{"date":"2024-07-12","current":-4.731908,"twenty":-7.26886,"median":-5.446277,"eighty":-2.760972,"marketCap":219801868},{"date":"2024-07-15","current":-4.776791,"twenty":-7.26886,"median":-5.446277,"eighty":-2.766106,"marketCap":221886709},{"date":"2024-08-02","current":-4.244611,"twenty":-7.27988,"median":-5.464392,"eighty":-2.838607,"marketCap":197166445},{"date":"2024-08-09","current":-1.761538,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":75082046},{"date":"2024-08-16","current":-1.425311,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":60751033},{"date":"2024-08-23","current":-1.491095,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":63554927},{"date":"2024-08-30","current":-1.396074,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":59504858},{"date":"2024-09-06","current":-1.257197,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":53585526},{"date":"2024-09-13","current":-1.43262,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":61062576},{"date":"2024-09-20","current":-1.374146,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":58570226},{"date":"2024-09-27","current":-1.308362,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":55766333},{"date":"2024-10-04","current":-1.301053,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":55454789},{"date":"2024-10-11","current":-1.191414,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":50781632},{"date":"2024-10-18","current":-1.257197,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":53585526},{"date":"2024-10-25","current":-1.22796,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":52339351},{"date":"2024-10-31","current":-1.301053,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":55454789},{"date":"2024-11-08","current":-1.3376,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":57012508},{"date":"2024-11-15","current":-1.258053,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":51473220},{"date":"2024-11-22","current":-1.12081,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":45857959},{"date":"2024-11-29","current":-1.097937,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":44922083},{"date":"2024-12-06","current":-0.930196,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":38058987},{"date":"2024-12-13","current":-0.95307,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":38994863},{"date":"2024-12-20","current":-0.853951,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":34939397},{"date":"2024-12-27","current":-0.983568,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":40242699},{"date":"2025-01-03","current":-0.960695,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":39306822},{"date":"2025-01-10","current":-0.998817,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":40866617},{"date":"2025-01-17","current":-0.930196,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38058987},{"date":"2025-01-24","current":-1.021691,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":41802493},{"date":"2025-01-31","current":-0.930196,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38058987},{"date":"2025-02-07","current":-0.876824,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":35875274},{"date":"2025-02-14","current":-0.838702,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":34315480},{"date":"2025-02-21","current":-0.937821,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38370945},{"date":"2025-02-28","current":-0.838702,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":34315480},{"date":"2025-03-07","current":-0.8692,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":35563315},{"date":"2025-03-14","current":-0.914947,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":37435069},{"date":"2025-03-21","current":-1.075063,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":43986206},{"date":"2025-03-28","current":-1.441042,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":58960233},{"date":"2025-04-04","current":-1.133862,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":43362288},{"date":"2025-04-11","current":-0.938087,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":35875274},{"date":"2025-04-17","current":-1.01966,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38994863},{"date":"2025-04-25","current":-1.035975,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":39618781},{"date":"2025-04-29","current":-1.060447,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":40554658}],"updateTime":1746085603980}}}